Medicine
Prochlorperazine 5 mg tablet
Prochlorperazine 5 mg tablet is a generic prescription medicine for oral use, made by 23 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20 to 25°C (68 to 77°F). Protect from light.
Key facts
- Active ingredient (INN)
- Prochlorperazine
- Brand
- Sold under the generic name
- Strength
- 5 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 1000 tablets, 90 tablets and 46 more
- Manufacturers
- Glenmark PharmaceuticalsIndiaJubilant Cadista PharmaceuticalsIndiaZydus LifesciencesIndiaAjanta PharmaIndiaAurobindo PharmaIndiaBryant Ranch PrepackBionpharmaA-S Medication SolutionsRedpharm DrugAmneal Pharmaceuticals NY23 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20 to 25°C (68 to 77°F). Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N05AB04 Prochlorperazine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 19 July 1996
- Identifiers
- RxCUI 198365, 312635DailyMed set ID b05bc20e-cd19-ab40-1ad0-84a115d6d69e, 459fbfd6-f6fe-4589-894f-acd69b413de6, c622550a-4f61-47f7-bc6b-9545d5d4e031 +25NDC 59746-113, 60687-814, 70518-4498 +25Application ANDA040268, ANDA216598, ANDA217478 +7
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 23 labelers. The register lists 49 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 70710-1667-1 | Zydus LifesciencesIndia | 10 August 2022 |
| 100 tablet in 1 bottle | 70771-1697-1 | Zydus LifesciencesIndia | 10 August 2022 |
| 100 tablet in 1 bottle | 27241-286-01 | Ajanta PharmaIndia | 9 May 2024 |
| 100 tablet, film coated in 1 bottle | 59651-773-01 | Aurobindo PharmaIndia | 8 September 2025 |
| 100 tablet in 1 bottle | 68462-889-01 | Glenmark PharmaceuticalsIndia | 17 March 2023 |
| 1000 tablet in 1 bottle | 68462-889-10 | Glenmark PharmaceuticalsIndia | 17 March 2023 |
| 100 tablet in 1 bottle | 59746-113-06 | Jubilant Cadista PharmaceuticalsIndia | 1 March 1998 |
| 1000 tablet in 1 bottle | 59746-113-10 | Jubilant Cadista PharmaceuticalsIndia | 1 March 1998 |
| 100 tablet, film coated in 1 bottle | 69452-309-20 | Bionpharma | 13 September 2023 |
| 1000 tablet, film coated in 1 bottle | 69452-309-32 | Bionpharma | 13 September 2023 |
| 100 tablet in 1 bottle | 69452-471-20 | Bionpharma | 31 January 2025 |
| 1000 tablet in 1 bottle | 69452-471-32 | Bionpharma | 31 January 2025 |
| 100 tablet, film coated in 1 bottle, plastic | 60219-2038-1 | Amneal Pharmaceuticals NY | 21 April 2023 |
| 1000 tablet, film coated in 1 bottle, plastic | 60219-2038-7 | Amneal Pharmaceuticals NY | 21 April 2023 |
| 100 tablet, film coated in 1 bottle | 70954-688-10 | ANI Pharmaceuticals | 1 August 2022 |
| 90 tablet, film coated in 1 bottle | 62135-673-90 | Chartwell RX | 25 March 2024 |
| 100 tablet, film coated in 1 bottle | 69315-265-01 | Leading Pharma | 25 June 2025 |
| 1 bottle in 1 box / 6 tablet in 1 bottle | 54348-989-06 | PharmPak | 11 July 2019 |
| 3 tablet, film coated in 1 bottle | 50090-7147-0 | A-S Medication Solutions | 26 April 2024 |
| 6 tablet, film coated in 1 bottle | 50090-7147-5 | A-S Medication Solutions | 1 May 2024 |
| 6 tablet in 1 bottle | 50090-7634-5 | A-S Medication Solutions | 18 August 2025 |
| 15 tablet, film coated in 1 bottle | 67296-2099-1 | Redpharm Drug | 13 September 2023 |
| 10 tablet, film coated in 1 bottle | 67296-2099-9 | Redpharm Drug | 13 September 2023 |
| 15 tablet in 1 bottle | 67296-2178-1 | Redpharm Drug | 31 January 2025 |
| 20 tablet in 1 bottle, plastic | 70518-4498-0 | Remedyrepack | 11 October 2025 |
| 20 tablet, film coated in 1 bottle, plastic | 70518-4728-0 | Remedyrepack | 19 August 2026 |
| 50 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack | 60687-814-65 | American Health Packaging | 14 October 2024 |
| 50 blister pack in 1 box / 1 tablet in 1 blister pack | 50268-684-15 | AvPAK | 16 April 2019 |
| 20 tablet, film coated in 1 bottle | 71335-2621-1 | Bryant Ranch Prepack | 24 March 2025 |
| 10 tablet, film coated in 1 bottle | 71335-2621-2 | Bryant Ranch Prepack | 24 March 2025 |
| 30 tablet, film coated in 1 bottle | 71335-2621-3 | Bryant Ranch Prepack | 24 March 2025 |
| 60 tablet, film coated in 1 bottle | 71335-2621-4 | Bryant Ranch Prepack | 24 March 2025 |
| 90 tablet, film coated in 1 bottle | 71335-2621-5 | Bryant Ranch Prepack | 24 March 2025 |
| 120 tablet, film coated in 1 bottle | 71335-2621-6 | Bryant Ranch Prepack | 24 March 2025 |
| 6 tablet, film coated in 1 bottle | 71335-2621-7 | Bryant Ranch Prepack | 24 March 2025 |
| 50 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack | 0904-7381-06 | Major Pharmaceuticals | 30 October 2023 |
| 6 tablet in 1 bottle | 51655-096-87 | Northwind Health | 28 April 2014 |
| 30 tablet in 1 bottle | 66267-271-30 | NuCare Pharmaceuticals | 7 November 2016 |
| 100 tablet, film coated in 1 bottle, plastic | 72789-517-01 | PD-Rx Pharmaceuticals | 28 July 2025 |
| 90 tablet, film coated in 1 bottle, plastic | 72789-517-90 | PD-Rx Pharmaceuticals | 28 July 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 23 October 1956 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Prochlorperazine
Clinical summary
Prochlorperazine is a phenothiazine. It is available as tablets, injection and suppositories for oral, intramuscular and intravenous use. MedsAcross supplies Prochlorperazine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ProchlorperazineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Prochlorperazine Edisylate prescribing information (Civica) · U.S. National Library of Medicine, DailyMed
Need Prochlorperazine 5 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.